Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob Schuringa

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Cell Reports. Medicine|January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemiaDiego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Blood Neoplasia|April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemiaNiels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Blood Cancer Journal|November 8, 2022
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagyKeli Lima, Diego Antonio Pereira-Martins, Lívia Bassani Lins de Miranda, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Haematologica|May 28, 2026
The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemiaCésar Alexander Ortiz Rojas, Diego Antonio Pereira-Martins, Carolina Hassibe Thomé, et al.
Blood|August 19, 2022
Dietary methionine starvation impairs acute myeloid leukemia progressionAlan Cunningham, Ayşegül Erdem, Islam Alshamleh, et al.
Cell Reports|January 24, 2019
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness PhenotypesGuoqiang Yi, Albertus T J Wierenga, Francesca Petraglia, et al.
Frontiers in Oncology|October 15, 2021
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant CellsLuciana Yamamoto de Almeida, Diego A Pereira-Martins, Isabel Weinhäuser, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Cell Reports. Medicine|January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemiaDiego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Blood Neoplasia|April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemiaNiels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Blood Cancer Journal|November 8, 2022
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagyKeli Lima, Diego Antonio Pereira-Martins, Lívia Bassani Lins de Miranda, et al.
Blood|June 2, 2012
Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myelomaRichard W J Groen, Willy A Noort, Reinier A Raymakers, et al.
Haematologica|May 28, 2026
The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemiaCésar Alexander Ortiz Rojas, Diego Antonio Pereira-Martins, Carolina Hassibe Thomé, et al.
Blood|August 19, 2022
Dietary methionine starvation impairs acute myeloid leukemia progressionAlan Cunningham, Ayşegül Erdem, Islam Alshamleh, et al.
Cell Reports|January 24, 2019
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness PhenotypesGuoqiang Yi, Albertus T J Wierenga, Francesca Petraglia, et al.
Frontiers in Oncology|October 15, 2021
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant CellsLuciana Yamamoto de Almeida, Diego A Pereira-Martins, Isabel Weinhäuser, et al.
Pageof 15